Ketamine Clinics in New Orleans, LA
Browse 10 ketamine therapy providers in New Orleans, Louisiana.
Erich Conrad
2475 Canal St Suite 106
New Orleans,
LA
70119
Integrated Behavioral Health
400 Poydras St STE 1950
New Orleans,
LA
70130
Ochsner Foundation Hosp & Phm
1516 Jefferson Hwy
New Orleans,
LA
70121
Jacob Rickoll
3637 Canal St Ste 100
New Orleans,
LA
70119
Erik Whitfield
1055 Saint Charles Ave STE 240
New Orleans,
LA
70130
Claudia Ukpolo
3201 General Degaulle Dr Ste 100
New Orleans,
LA
70114
Peter Mahony
3439 Magazine St
New Orleans,
LA
70115
Michael Walsh
478 S Johnson St Fl 7
New Orleans,
LA
70112
Haley Williams
1616 Fats Domino Ave Fl 2
New Orleans,
LA
70117
Elysian Wellness
3915 Baronne St STE 201
New Orleans,
LA
70115
Ketamine Treatments in New Orleans
Explore ketamine treatment options available in New Orleans, Louisiana.
IV Ketamine Infusion
Off-label psychiatric use. Verify protocols, evidence, risks, and pricing with the provider.
IM Injection
Off-label psychiatric use. Availability and clinical protocols vary by provider.
Spravato (Esketamine)
FDA-approved nasal spray administered in a REMS-certified healthcare setting.
Ketamine-Assisted Psychotherapy
Off-label and still under study. Evidence, training, and protocols vary.
Compare source evidence in New Orleans, Louisiana
These 10 directory records are starting points for checking providers. 10 carry an imported Spravato REMS flag and 0 come from ASKP membership data. Neither an NPI entry nor association membership confirms a particular therapy, current intake, price or suitability.
No additional provider-site service check has been recorded for this city cohort. Confirm each listed service directly.
Questions before choosing a service
- Which exact medicine, formulation and route does this location offer? Distinguish Spravato from other ketamine products.
- Who evaluates eligibility, and how can you verify that clinician’s state licence?
- What observation, follow-up and urgent-care arrangements does the provider explain?
- What does the written total include: evaluation, medicine, monitoring, follow-up and any facility fee? Confirm coverage with your insurer.
FDA maintains compounding risk alerts, including its ketamine alerts. Read the current product information and discuss risks and alternatives with your treating clinician. Directory inclusion is not a treatment recommendation or a guarantee of availability.
Directory sources and limits · Spravato information · Questions and treatment distinctions